Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.39 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.39 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8734332 | 1.00 | ELANE (0.39) | ELANEPTGDRPTGDR2CAMK2AMEN1 | |
| SCHEMBL13002803 | 0.84 | ELANE (0.36) | ELANEPTGDRPTGDR2MEN1KMT2A | |
| SCHEMBL3801608 | 0.83 | KDM4E (0.42) | SRC | |
| SCHEMBL2142447 | 0.83 | KDM4E (0.42) | SRC | |
| SCHEMBL21883503 | 0.81 | ELANE (0.41) | ELANEPTGDRPTGDR2MEN1KMT2A | |
| SCHEMBL13337570 | 0.79 | MEN1 (0.37) | ELANEPTGDRPTGDR2MEN1KMT2A | |
| SCHEMBL13789695 | 0.78 | TDP1 (0.46) | ELANEPTGDRPTGDR2MEN1KMT2A | |
| SCHEMBL541751 | 0.75 | KDM4E (0.44) | TDP1 | |
| SCHEMBL31127744 | 0.75 | KDM4E (0.44) | TDP1 | |
| SCHEMBL7656115 | 0.75 | GABRA1 (0.40) | MEN1KMT2ASRCMAPTGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6479688-B2 | FROM REACTING TERT-BUTYLHYDROQUINONE AND MONOPHENYL DICHLOROPHOSPHATE IN PRESENCE OF ACID CATALYST; FLAME RETARDANTS | AKZO NOBEL NV (NL) | 2002-11-12 | — | — | US | disclosed |
| US-6479688-B2 | FROM REACTING TERT-BUTYLHYDROQUINONE AND MONOPHENYL DICHLOROPHOSPHATE IN PRESENCE OF ACID CATALYST; FLAME RETARDANTS | AKZO NOBEL NV (NL) | 2002-11-12 | — | — | US | disclosed |
| US-20020151739-A1 | PROCESS FOR MAKING DI(HYDROXYALKYLARYL) ARYL PHOSPHATE COMPOUNDS | ICL-IP AMERICA INC. | 2002-10-17 | — | — | US | disclosed |
| US-20020151739-A1 | PROCESS FOR MAKING DI(HYDROXYALKYLARYL) ARYL PHOSPHATE COMPOUNDS | ICL-IP AMERICA INC. | 2002-10-17 | — | — | US | disclosed |
| US-6403819-B1 | REACTING ORTHO-ALKYL SUBSTITUTED AROMATIC DIOL AND MONOARYL DIHALOPHOSPHATE | AKZO NOBEL, NV (NL) | 2002-06-11 | — | — | US | disclosed |
| US-6403819-B1 | REACTING ORTHO-ALKYL SUBSTITUTED AROMATIC DIOL AND MONOARYL DIHALOPHOSPHATE | AKZO NOBEL, NV (NL) | 2002-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020151739-A1 | PROCESS FOR MAKING DI(HYDROXYALKYLARYL) ARYL PHOSPHATE COMPOUNDS | GNPAT, DHODH, DDT | ELANE 4136/4885PTGDR 860/4885PTGDR2 1418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.